PlainRecalls
FDA Drug Critical Class I Terminated

MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88

Reported: February 16, 2022 Initiated: February 4, 2022 #D-0557-2022

Product Description

MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88

Reason for Recall

Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Details

Recalling Firm
Junp Hydration LLC
Units Affected
750 cartons
Distribution
Product was distributed nationwide in the USA via Amazon Marketplace
Location
Brooklyn, NY

Frequently Asked Questions

What product was recalled?
MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88. Recalled by Junp Hydration LLC. Units affected: 750 cartons.
Why was this product recalled?
Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 16, 2022. Severity: Critical. Recall number: D-0557-2022.